Results 261 to 270 of about 55,594 (335)
JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review
Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova +9 more
wiley +1 more source
Paradoxical lichenoid drug eruption following dupilumab use for atopic dermatitis: A case report. [PDF]
Gandhi M, Vanderbeck K, Giroux L.
europepmc +1 more source
Mechanisms Underlying Lichen Planus in Association with Biologic Therapy. [PDF]
Podolsky AS, Lipner SR.
europepmc +1 more source
Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies. [PDF]
Marino M +8 more
europepmc +1 more source
Drug eruption induced by the intake of comprehensive cold medicine: A case report. [PDF]
Huang Y +5 more
europepmc +1 more source
The Enigma of Paradoxical Reactions to Biological Therapies. [PDF]
Elbendary A +6 more
europepmc +1 more source
Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis. [PDF]
Parga AD, Dubin C, Rudikoff D.
europepmc +1 more source
Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment. [PDF]
Devireddy T +4 more
europepmc +1 more source

